Tumor-related interleukins: old validated targets for new anti-cancer drug development
S Setrerrahmane, H Xu - Molecular cancer, 2017 - Springer
In-depth knowledge of cancer molecular and cellular mechanisms have revealed a strong
regulation of cancer development and progression by the inflammation which orchestrates …
regulation of cancer development and progression by the inflammation which orchestrates …
Interleukins in cancer: from biology to therapy
Interleukins and associated cytokines serve as the means of communication for innate and
adaptive immune cells as well as non-immune cells and tissues. Thus, interleukins have a …
adaptive immune cells as well as non-immune cells and tissues. Thus, interleukins have a …
Is interleukin‐1 a good or bad 'guy'in tumor immunobiology and immunotherapy?
RN Apte, E Voronov - Immunological reviews, 2008 - Wiley Online Library
The interleukin‐1 (IL‐1) family consists of two major agonistic proteins, IL‐1α and IL‐1β,
which are pleiotropic and affect mainly inflammation, immunity, and hemopoiesis. The IL‐1 …
which are pleiotropic and affect mainly inflammation, immunity, and hemopoiesis. The IL‐1 …
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
K Taniguchi, M Karin - Seminars in immunology, 2014 - Elsevier
Inflammatory responses play pivotal roles in cancer development, including tumor initiation,
promotion, progression, and metastasis. Cytokines are now recognized as important …
promotion, progression, and metastasis. Cytokines are now recognized as important …
Roles of IL-1 in cancer: from tumor progression to resistance to targeted therapies
V Gelfo, D Romaniello, M Mazzeschi, M Sgarzi… - International journal of …, 2020 - mdpi.com
IL-1 belongs to a family of 11 members and is one of the seven receptor-agonists with pro-
inflammatory activity. Beyond its biological role as a regulator of the innate immune …
inflammatory activity. Beyond its biological role as a regulator of the innate immune …
[HTML][HTML] New perspectives in cancer immunotherapy: targeting IL-6 cytokine family
Chronic inflammation has been recognized as a canonical cancer hallmark. It is
orchestrated by cytokines, which are master regulators of the tumor microenvironment (TME) …
orchestrated by cytokines, which are master regulators of the tumor microenvironment (TME) …
IL‐1 and IL‐1 regulatory pathways in cancer progression and therapy
A Mantovani, I Barajon, C Garlanda - Immunological reviews, 2018 - Wiley Online Library
Inflammation is an important component of the tumor microenvironment. IL‐1 is an
inflammatory cytokine which plays a key role in carcinogenesis and tumor progression. IL‐1 …
inflammatory cytokine which plays a key role in carcinogenesis and tumor progression. IL‐1 …
Therapeutic strategies for targeting IL-1 in cancer
Simple Summary Interleukin-1 cytokines are key proinflammatory cytokines which have
been implicated with differing pro-and antitumorigenic properties. Recent years have …
been implicated with differing pro-and antitumorigenic properties. Recent years have …
Mechanisms and αpplications of ιnterleukins in cancer immunotherapy
D Anestakis, S Petanidis, S Kalyvas, CM Nday… - International journal of …, 2015 - mdpi.com
Over the past years, advances in cancer immunotherapy have resulted in innovative and
novel approaches in molecular cancer diagnostics and cancer therapeutic procedures …
novel approaches in molecular cancer diagnostics and cancer therapeutic procedures …
Interleukin-1 in tumor progression, therapy, and prevention
C Garlanda, A Mantovani - Cancer cell, 2021 - cell.com
Summary Interleukin-1 (IL-1) is a key orchestrator of inflammation and plays an important
role in tumor progression. Based on preclinical models and human genetic associations, we …
role in tumor progression. Based on preclinical models and human genetic associations, we …